Atlas Trials

Initial Clinical and CBCT Outcomes of Enamel Matrix Derivative-Based Regenerative Therapy in Vertical Bone Defects

Clinical trial NCT06639555 · COMPLETED

Trial details

NCT number
NCT06639555
Sponsor
Tsvetalina Gerova-Vatsova
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Vertical Alveolar Bone Loss
Start date
2022-06-24
Primary completion
2023-02-15
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.